Molecular Formula | C10H15N3S |
Molar Mass | 209.31 |
Density | 1.167±0.06 g/cm3(Predicted) |
Boling Point | 364.6±37.0 °C(Predicted) |
pKa | 7.22±0.20(Predicted) |
Storage Condition | Room Temprature |
Physical and Chemical Properties | Talikol dihydrochloride (Talipexole Dihydrochloride):C10H15N3S?2HCl. [36085-73-1]. Melting point 245 ℃ (decomposition). |
Overview | Tagrisso (6-allyl-2-amino-5, 6,7, 8-tetrahydro-4h-thiazole [4,5-d]-Aza-dihydrochloride) is a selective dopamine D2 receptor agonist, it inhibits dopamine release from uninjured areas of dopamine nerve endings and reduces dopaminergic neurotransmission, I .e., by selectively stimulating dopamine D2 receptors in the postsynaptic membrane of the striatum, thereby producing an anti-Parkinson effect. |
pharmacological action | tamoxifen has both α2-adrenergic receptor and selective dopamine D2 receptor agonist activity, it inhibits dopamine release from intact areas of dopamine nerve endings and reduces dopaminergic nerve conduction. Tamoxifen is effective in all major PD symptoms in subjects and is effective in reducing the severity of failure and ameliorating side effects such as circadian fluctuations and dyskinesia. |
Use | α1-D2 agonist. For the treatment of Parkinson's disease. |
production method | the compound (I) and thiourea are condensed and cyclized to obtain tacrolimus. |